Influenza Medications Market, By Drug Type (Antiviral Drugs, Antihistamines, Analgesics and Antipyretics), By Influenza Type, By Age Group, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Influenza Medications Market size was valued at USD 932.43 million in 2023, expanding at a CAGR of 7.2% from 2024 to 2032.
Medications for influenza are utilized to either treat or prevent infections caused by the flu. Antiviral drugs that target influenza viruses serve as a crucial complement to the influenza vaccine in managing the disease. These antiviral agents function by hindering the replication of the influenza virus, which in turn alleviates the severity and shortens the duration of symptoms. Their efficacy is maximized when administered promptly, preferably within 48 hours of the onset of symptoms. Thus, influenza medications play a vital role in alleviating flu symptoms and mitigating the overall effects of the infection.
Influenza Medications Market- Market Dynamics
The increasing incidence of influenza is expected to drive the growth of the market
Influenza is a recurring illness that manifests seasonally, resulting in annual outbreaks across various regions globally. The heightened occurrence during the flu season leads to an increased demand for pharmaceutical interventions. Additionally, sporadic flu pandemics or epidemics can considerably elevate the incidence of influenza, resulting in surges in the need for antiviral therapies and preventive strategies. The Centers for Disease Control and Prevention (CDC) estimates that this season has witnessed at least 35 million cases, 400,000 hospitalizations, and 25,000 fatalities attributed to the flu. Moreover, advancements in the development of antiviral medications and integrated treatment methodologies present significant growth opportunities for the market. Nonetheless, the high costs associated with novel medications may pose challenges to market expansion.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INFLUENZA MEDICATIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
AstraZeneca plc
Teva Pharmaceutical Industries Ltd
BioCryst Pharmaceuticals, Inc.
Sanofi
Daiichi Sankyo Company
Novartis AG
F. Hoffmann-La Roche AG
NATCO Pharma Limited
GlaxoSmithKline plc
Lupin
Others
GLOBAL INFLUENZA MEDICATIONS MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032
Antiviral Drugs
o Single Antiviral Drugs
o Combination Antiviral Drugs
Antihistamines
Analgesics
Antipyretics
GLOBAL INFLUENZA MEDICATIONS MARKET, BY INFLUENZA TYPE- MARKET ANALYSIS, 2019 - 2032
Influenza A
Influenza B
GLOBAL INFLUENZA MEDICATIONS MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019 - 2032
Adults
Pediatric
Geriatric
GLOBAL INFLUENZA MEDICATIONS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
Oral
Inhaled
Intravenous
GLOBAL INFLUENZA MEDICATIONS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
GLOBAL INFLUENZA MEDICATIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Influenza Medications Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Influenza Medications Market Snippet by Drug Type
2.1.2. Influenza Medications Market Snippet by Influenza Type
2.1.3. Influenza Medications Market Snippet by Age Group
2.1.4. Influenza Medications Market Snippet by Route of Administration
2.1.5. Influenza Medications Market Snippet by Distribution Channel
2.1.6. Influenza Medications Market Snippet by Country
2.1.7. Influenza Medications Market Snippet by Region
2.2. Competitive Insights
3. Influenza Medications Key Market Trends
3.1. Influenza Medications Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Influenza Medications Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Influenza Medications Market Opportunities
3.4. Influenza Medications Market Future Trends
4. Influenza Medications Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Influenza Medications Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Influenza Medications Market Landscape
6.1. Influenza Medications Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Influenza Medications Market – By Drug Type
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
7.1.2. Antiviral Drugs
7.1.2.1. Single Antiviral Drugs
7.1.2.2. Combination Antiviral Drugs
7.1.3. Antihistamines
7.1.4. Analgesics
7.1.5. Antipyretics
8. Influenza Medications Market – By Influenza Type
8.1. Overview
8.1.1. Segment Share Analysis, By Influenza Type, 2023 & 2032 (%)
8.1.2. Influenza A
8.1.3. Influenza B
9. Influenza Medications Market – By Age Group
9.1. Overview
9.1.1. Segment Share Analysis, By Age Group, 2023 & 2032 (%)
9.1.2. Adults
9.1.3. Pediatric
9.1.4. Geriatric
10. Influenza Medications Market – By Route of Administration
10.1. Overview
10.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
10.1.2. Oral
10.1.3. Inhaled
10.1.4. Intravenous
11. Influenza Medications Market – By Distribution Channel
11.1. Overview
11.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
11.1.2. Hospital Pharmacies
11.1.3. Retail Pharmacies
11.1.4. Online Pharmacies
12. Influenza Medications Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Influenza Medications Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Influenza Medications Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.10. Italy
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.10.4. Italy Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.3.10.5. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.3.10.6. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.10.7. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.11. United Kingdom
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.11.4. United Kingdom Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.3.11.5. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.3.11.6. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.11.7. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.12. France
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.12.4. France Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.3.12.5. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.3.12.6. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.12.7. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.13. Russia
12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.2. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.13.3. Russia Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.3.13.4. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.3.13.5. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.13.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.14. Netherlands
12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.2. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.14.3. Netherlands Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.3.14.4. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.3.14.5. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.14.6. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.2. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.16. Poland
12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.2. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.16.3. Poland Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.3.16.4. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.17. Rest of Europe
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.3.17.4. Rest of the Europe Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.3.17.5. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.3.17.6. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.17.7. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Influenza Medications Key Manufacturers in Asia Pacific
12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.5. Asia Pacific Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.4.6. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.4.7. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.8. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.9. India
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.9.4. India Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.4.9.5. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.4.9.6. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.9.7. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.10. China
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.10.4. China Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.4.10.5. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.4.10.6. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.10.7. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.14. Thailand
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.14.4. Thailand Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.4.14.5. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.4.14.6. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.14.7. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.15. Indonesia
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.15.4. Indonesia Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.4.15.5. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.4.15.6. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.15.7. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5. Latin America
12.5.1. Overview
12.5.2. Influenza Medications Key Manufacturers in Latin America
12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.5. Latin America Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.5.6. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.5.7. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.8. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Influenza Medications Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Influenza Type, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Influenza Medications Industry
13.1. Competitive Dashboard
13.2. Company Profiles
13.2.1. AstraZeneca plc
13.2.2. Teva Pharmaceutical Industries Ltd
13.2.3. BioCryst Pharmaceuticals, Inc.
13.2.4. Sanofi
13.2.5. Daiichi Sankyo Company
13.2.6. Novartis AG
13.2.7. F. Hoffmann-La Roche AG
13.2.8. NATCO Pharma Limited
13.2.9. GlaxoSmithKline plc
13.2.10. Lupin
13.2.11. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
